Please assess the completion status of the following clinical trial:

Trial Title: Default BP Medication Intensification

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* 18 to 55 years old~* office BP of ≥160 mmHg systolic and ≥100 mmHg diastolic (treated or untreated) AND \<180 mmHg systolic.~Exclusion Criteria:~* chronic kidney disease~* symptomatic coronary artery disease~* congestive heart failure~* more than mild valvular heart disease~* Diabetes mellitus~* obstructive left ventricular hypertrophy~* severe electrolyte abnormalities~* multiple medication intolerances~* orthostatic hypotension~* cognitive impairment and mental disorders affecting ability to self-monitor BP~* patients who are unwilling to measure and transmit BP readings throughout the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- default intensification arm (all) (Type: EXPERIMENTAL): all subjects will receive blister packs with weekly increasing blood pressure medications. There is no control arm for this study

Based on this trial design, predict the completion outcome and termination type (if applicable).